Plants - the bio-reactor of the future
As we discover more of what our plants are capable of expressing, so our pipeline of products grows. Our focus is across key research areas such as communicable (eg HIV) and non-communicable diseases (eg. Cancer).
Most of our products are fused with a variety of conjugates as well as a variety of sizes e.g nanobodies, ScfV, Fab or Full length immunoglobulins. We have the exclusive licence for the patent pending plant-based HRP-Fusion protein held by the University of Cape Town.
Our ‘PtX-1 shot’ range, like our anti-HIV1 p24 full (human or rabbit backbone) conjugated to HRP is both a primary and a secondary in one. Hence ‘1-shot’ saving you time and stress.
And being recombinant, we can add different constant region backbones to all our products.
Please click on product links for more information, data sheet and confirmation of availability.
Some products are still in final testing and may not be ex-stock.
"PtX-1 Shot" Range - Primary Monoclonal Antibodies
These are already conjugated to HRP so no need for a secondary - saves time and money.
ANTI-BOVINE SERUM ALBUMIN (BSA) ANTIBODIES
CBP_0001.1 PtX™ 1-Shot* Anti-Bovine Serum Albumin, scFv-HRP
CBP_0001.2 PtX™ Anti-Bovine Serum Albumin, Full IgG (Human)
CBP_0001.3 PtX™ Anti-Bovine Serum Albumin, Full IgG (Rabbit)
ANTI-HIV-1 P24 ANTIBODIES
CBP_0002.1 PtX™ 1-Shot* Anti-HIV-1 p24 scFv-HRP
CBP_0002.2 PtX™ 1-Shot* Anti-HIV-1 p24, Full IgG (Human)-HRP
CBP_0002.3 PtX™ Anti-HIV-1 p24, Full IgG (Human)
CBP_0002.4 PtX™ Anti-HIV-1 p24, Full IgG (Rabbit)
ANTI-HUMAN IGG ANTIBODY
CBP_0003.1 PtX™ 1-Shot* Anti-Human IgG, scFv-HRP
ANTI-GLUTATHIONE S TRANSFERASE (GST) ANTIBODIES
CBP_0004.1 PtX™ 1-Shot* Anti-GST, scFv-HRP
CBP_0004.4 PtX™ Anti-GST, Full IgG1 (Rabbit)
ANTI-INTERFERON GAMMA (IFNy) ANTIBODY
CBP_0005.4 PtX™ Anti-Interferon gamma, Full IgG1 (Rabbit)
ANTI-BETA TUBULIN ANTIBODY
CBP_0006.1 PtX™ 1-Shot* Anti-beta tubulin, Full IgG1(Rabbit)-HRP
CBP_0011.1 PtX™ Bovine Serum Albumin (BSA), ultrapure, recombinant
CBP_0012.1 PtX™ Horseradish Peroxidase (HRP), Isotype C, recombinant
CBP_0013.1 PtX™ Protein A (SpA), recombinant
CBP_0014.1 PtX™ Protein A-HRP fusion (SpA-HRP), recombinant
CBP_0015.1 PtX™ p24 HIV-1 antigen (South African subtype C strain)
CBP_0016.1 PtX™ enhanced Green Fluorescent Protein (eGFP) antigen
CBP_0017.1 PtX SupaTag™** Fusion Protein
Antibodies are the most widely used class of protein-binding reagents and continue to be the gold-standard choice for protein identification, detection, modifications and alterations as well as for monitoring expression and cellular regulation. They are fundamental, irreplaceable tools for the work of life scientists. Read more on the critical role antibodies play in research today.
Within the global antibody production market, there is a reproducibility crisis. Many researchers are struggling to not only reproduce results of other researchers but also their own results. Many argue that antibodies are a large part of this problem. One of the key issues with antibodies produced in traditional mammalian expression systems is that each batch is different leading to these reproducibility challenges. Plant-based antibodies can guarantee reproducibility in that the exact same genetic construct is reproduced in plants each and every batch.
Plants are capable at producing very complex proteins, and as we discover more of what our plants are capable of expressing, so does our pipeline of products grow. Our focus is across key main research areas such as communicable (eg HIV) and noncommunicable diseases (eg Cancer). Most of our products are fused with a variety of conjugates such as HRP, AP, GFP. This fusion takes place at genetic level ensuring consistent and reproducible conjugated reagents. We also provide a variety of sizes for different applications e.g. nanobodies, ScFv, Fab or Full length immunoglobulins.
Our ‘ptX-1 shot’ range, like our anti-HIV1 p24 Full IgG (Human) conjugated to HRP is both a primary and a secondary in one. Hence ‘one-shot’ saving time and stress.
Our current product line focuses on building a library of monoclonal primary and secondary antibodies used as research reagents. Our plant-based platform has the potential to expand into producing proteins for diagnostic kits, animal vaccines, human vaccines and eventually therapeutics.
Our plant grow-room and laboratory facility is able to produce purified and quality tested product ready for distribution on a weekly basis.